AVITA Medical, Inc. (RCEL) Exchange Rate Effect (2019 - 2023)

AVITA Medical (RCEL) has reported Exchange Rate Effect for 5 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2023.

• For the quarter ending Q4 2023, Exchange Rate Effect fell 102.27% year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2023 stood at -$16000.0 (up 50.0% YoY), and the FY2023 full-year result was -$16000.0, up 38.46% from the prior year.
• Exchange Rate Effect climbed to -$1000.0 in Q4 2023 per RCEL's latest filing, from -$18000.0 in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $127000.0 in Q3 2020 and bottomed at -$68000.0 in Q1 2020.
• Historically, Exchange Rate Effect has averaged $6800.0 across 5 years, with a median of -$1000.0 in 2023.
• The sharpest annual moves came in 2020 and 2021: Exchange Rate Effect soared 677.27% in 2020, then slumped 143.31% in 2021.
• Over 5 years, Exchange Rate Effect stood at $48000.0 in 2019, then sank by 35.42% to $31000.0 in 2020, then plunged by 277.42% to -$55000.0 in 2021, then soared by 180.0% to $44000.0 in 2022, then plunged by 102.27% to -$1000.0 in 2023.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1000.0, -$18000.0, and $2000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.